本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2011/4/151 分钟阅读
Determination of Regulatory Review Period for Purposes of Patent Extension; ATRYN; Correction
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of March 21, 2011 (76 FR 15323). The document announced the determination of the regulatory review period for ATRYN. The document was published with an incorrect docket number. This document corrects that error.
来源原始语言: Federal Register — Health and Human Services打开原始公告 →